Cardoso José Carlos, Teixeira Vera, Tchernev Georgi, Wollina Uwe
Wien Med Wochenschr. 2013 Aug;163(15-16):359-67. doi: 10.1007/s10354-013-0218-0.
Merkel cell carcinoma (MCC) or primary cutaneous neuroendocrine carcinoma is a relatively uncommon form of skin cancer. It is an aggressive neoplasm with high tendency for local recurrence and lymph node and distant metastasis, whose incidence has been rising in the last 2 decades.A novel polyomavirus (MCPyV) has been found in a significant proportion of MCCs, and this finding significantly contributed to the understanding of its pathogenesis.It is fairly consensual at the current state of know-ledge that appropriate staging, including sentinel lymph node biopsy, is very important in order to plan adequate treatment. Treatment includes aggressive surgery of the primary tumour and lymph node basin, commonly combined with adjuvant radiotherapy. Chemotherapy is usually reserved for distant metastasis.In the present article, the authors review the current knowledge about MCC with special emphasis on the new pathogenetic findings and current recommendations regarding management.
默克尔细胞癌(MCC)或原发性皮肤神经内分泌癌是一种相对罕见的皮肤癌形式。它是一种侵袭性肿瘤,具有较高的局部复发、淋巴结转移和远处转移倾向,在过去20年中其发病率一直在上升。在相当一部分MCC中发现了一种新型多瘤病毒(MCPyV),这一发现对理解其发病机制有重要意义。就目前的知识水平而言,人们普遍认为,包括前哨淋巴结活检在内的适当分期对于规划充分的治疗非常重要。治疗包括对原发性肿瘤和淋巴结区域进行积极手术,通常联合辅助放疗。化疗通常用于远处转移。在本文中,作者回顾了关于MCC的当前知识,特别强调了新的发病机制研究结果和当前的治疗建议。